Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Payables (2023 - 2025)

Rallybio's Payables history spans 3 years, with the latest figure at $269000.0 for Q3 2025.

  • For Q3 2025, Payables fell 53.86% year-over-year to $269000.0; the TTM value through Sep 2025 reached $269000.0, down 53.86%, while the annual FY2024 figure was $278000.0, 71.52% down from the prior year.
  • Payables for Q3 2025 was $269000.0 at Rallybio, up from $119000.0 in the prior quarter.
  • Across five years, Payables topped out at $1.2 million in Q2 2024 and bottomed at $119000.0 in Q2 2025.
  • The 3-year median for Payables is $470000.0 (2024), against an average of $568000.0.
  • The largest annual shift saw Payables skyrocketed 76.78% in 2024 before it crashed 90.23% in 2025.
  • A 3-year view of Payables shows it stood at $976000.0 in 2023, then crashed by 71.52% to $278000.0 in 2024, then dropped by 3.24% to $269000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Payables are $269000.0 (Q3 2025), $119000.0 (Q2 2025), and $400000.0 (Q1 2025).